WHO: Six COVID-19 Vaccines Are Undergoing Clinical Trials
World leaders have pledged to accelerate collaboration in developing a coronavirus vaccine, as well as distribute COVID-19 patient treatments and medications around the world. The United States refused to participate in a virtual meeting, which was convened at the initiative of the world health organization.
As the Guardian notes, the meeting, which was attended by many G20 leaders, demonstrated the growing isolation of Donald Trump on the world stage. The main result of the event was the decision that rich countries will not hide the results of research on the development of a vaccine from developing countries.
The meeting also showed support for WHO from world leaders amid Trump's decision to suspend payments to the organization. The parties agreed to hold a joint global summit on the fight against coronavirus on the fourth of May, under the British chairmanship, aimed at raising funds for research, treatment, and testing of vaccines.
"We face a common threat that can be overcome by working together. Experience tells us that virus medications are not equally available to everyone. We cannot allow this to happen," said WHO Director-General Tedros Adhanom Ghebreyesus.
According to Seth Berkley, Director General of the Gavi Alliance, which leads immunization campaigns in poor countries and actively cooperates with WHO, more than 100 potential COVID-19 vaccines are being developed worldwide, six of them are already undergoing clinical trials. According to Berkeley, it is necessary to prevent a repeat of the experience of 2009, when the H1N1 swine flu vaccine reached developing countries too late.
The participants agreed on the final text of the document, committing themselves to ensure access to new treatments, technologies, and vaccines around the world, to adhere to a global international partnership in research and coordination of efforts to combat the pandemic, to make collective decisions to respond to the pandemic, as well as to learn from the experience of other countries, to be responsible to the most vulnerable communities and the world.
Analysts say the very multi-sided and declarative tone of the promises contrasts with the response of many countries to the outbreak of the pandemic. In fact, many states have banned the export of medical equipment from their countries, closed borders, and even tried to steal equipment from each other. The degree of collaboration in vaccine research is also uneven.
The meeting decided to appoint two new special envoys to coordinate collaboration in vaccine research and ensure equal access to any successful vaccines. They were sir Andrew witty, former head of the British pharmaceutical giant GSK, and Dr. Ngozi Okonjo-Iweala, Chairman of Gavi.